Rating History for Nabriva Therapeutics AG (NBRV) by Northland
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 1/6/2023 | Carl Byrnes | Downgrade | Underperform (Outperform) |
1.00 (8.00) |
2.36 (1.42) |
-39.83% | Details |
 |
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
